At present, although China's pharmaceutical machinery industry has made some progress, but there are still some problems in the process of development, such as low-grade products flooding the leading market, a small part of high-grade, high-precision, high-strength pharmaceutical machinery equipment still need to be imported; product structure is incomplete, low-end market products oversupply. In response, experts said domestic pharmaceutical machinery to high-end technology to achieve transformation and upgrading.
Low-end products still fill the market for pharmaceutical machinery
Although the development of domestic pharmaceutical machinery industry has made great progress, but there are still many problems. The market order is chaotic; the product structure is incomplete, the low-end market product supply exceeds the demand; the enterprise technology level is relatively low, the independent research and development independent innovation ability is not strong these problems have hindered the healthy development of the pharmaceutical equipment industry to a great extent.
At present, the production of domestic pharmaceutical machinery is still dominated by low-grade products, a small part of high-grade, high-precision and high-strength pharmaceutical machinery equipment still needs to be imported, the ratio of unit price of product import to unit price of export is more than 6 times, the gap with the United States, Japan and South Korea, Taiwan is large, and the lack of technical services to solve mechanical fastening solutions to achieve the digitization of products, design, manufacturing and management, products and manufacturing process green.
Compared with foreign pharmaceutical machinery industry, domestic pharmaceutical machinery industry has certain advantages and there is a gap. Compared with the western pharmaceutical machinery industry, China's pharmaceutical machinery industry has two major competitive advantages: on the one hand, it has a low-cost competitive advantage; on the other hand, the implementation of the new version of the domestic GMP, the rapid growth of the pharmaceutical machinery market, which provides an important support for the development of the pharmaceutical machinery industry in China. The market space of China's sustained growth is a prerequisite for the domestic industry to maintain its advantages.
Transformation of Domestic Pharmaceutical Machinery: Towards High-end Technology
At present, China's pharmaceutical machinery industry economic indicators have declined, including new orders and production and marketing level. At the same time, the large increase in capital occupation has also created a large number of idle resources, reducing efficiency. Under the background of the current macroeconomic downturn, enterprises should break through the predicament, reverse the situation, the road of transformation is very clear, that is, to the high-end technology.
In the past few years, the technological development trend of pharmaceutical machinery industry in China has become more and more consistent with that of its peers in the world, but the overall technical level is low, and in the field of products with high, fine and sharp technology content, the supply of products is in short supply. Therefore, research and development of high-end products adapted to China's domestic market has become a shortcut for Chinese pharmaceutical machinery enterprises to survive.